Michael Antoniou, PhD is a Reader in Molecular Genetics and Head of the Gene Expression and Therapy Group, Department of Medical and Molecular Genetics, King’s College London School of Medicine, UK. He has 34 years’ experience of using genetic engineering technology, including genome-editing tools, in the investigation of gene organization and control, with over 100 peer-reviewed publications. He holds inventor status on gene expression biotechnology patents. His discoveries in gene control mechanisms are being used for research as well as the development of diagnostic and therapeutic products for genetic disorders. Dr Antoniou has taken an active interest in the safety of GM crops and their associated pesticides. In recent years he has published papers demonstrating the non-equivalence of glyphosate-tolerant GM corn and non-GM corn and severe kidney and liver toxicity from chronic exposure to an ultra-low dose of Roundup.